PBH 📈 Prestige Brand Holdings - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74112D1019
PBH: Pain Relievers, Skincare, Eye Care, Dental Care, Digestive Aid
Prestige Consumer Healthcare Inc. is a leading developer, manufacturer, and distributor of over-the-counter (OTC) health and personal care products, with a presence in North America, Australia, and international markets. The company's product portfolio is diverse, comprising a range of well-known brands such as BC and Goody's analgesic powders, Boudreaux's Butt Paste for diaper rash treatments, and Chloraseptic for sore throat relief. Additionally, the company offers Clear Eyes for eye care, Compound W for at-home wart removal, and Debrox for ear wax removal, among other products. These brands cater to various consumer needs, from pain relief and skincare to oral care and digestive health.
The company operates through two main segments: North American OTC Healthcare and International OTC Healthcare. This structure enables Prestige Consumer Healthcare to tailor its product offerings and marketing strategies to specific regional needs and preferences. Its product lineup also includes DenTek dental care products, Dramamine for motion sickness, Fleet enemas and laxatives, and Gaviscon for upset stomach relief. Furthermore, the company offers Luden's cough drops, Monistat for yeast infections, Nix for lice and parasite treatments, and Summer's Eve feminine care products, demonstrating its commitment to addressing a broad spectrum of consumer health and personal care requirements.
Prestige Consumer Healthcare's distribution network is extensive, with products sold through various channels including mass merchandisers, drug stores, food stores, dollar stores, convenience stores, and club stores. The company also leverages e-commerce platforms to reach a wider audience and provide consumers with the convenience of online shopping. This multi-channel approach allows the company to maximize its reach and availability, making its products accessible to a large and diverse consumer base. With a history dating back to 1996 and headquarters in Tarrytown, New York, Prestige Consumer Healthcare has established itself as a significant player in the OTC health and personal care market.
The company's evolution is marked by its name change from Prestige Brands Holdings, Inc. to Prestige Consumer Healthcare Inc. in August 2018, reflecting its focus on the consumer healthcare sector. As a publicly traded company listed on the New York Stock Exchange (NYSE) under the ticker symbol PBH, Prestige Consumer Healthcare is committed to delivering value to its shareholders while meeting the evolving needs of its consumers. With a strong portfolio of brands and a robust distribution network, the company is well-positioned to navigate the competitive landscape of the OTC health and personal care industry.
Additional Sources for PBH Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PBH Stock Overview
Market Cap in USD | 4,114m |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
GiC Sub-Industry | Pharmaceuticals |
IPO / Inception | 2005-02-10 |
PBH Stock Ratings
Growth 5y | 71.6% |
Fundamental | 57.9% |
Dividend | 0.30% |
Rel. Strength Industry | 3598 |
Analysts | 4.13/5 |
Fair Price Momentum | 81.43 USD |
Fair Price DCF | 133.34 USD |
PBH Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | 0.00% |
Payout Consistency | 1.0% |
PBH Growth Ratios
Growth Correlation 3m | 71.2% |
Growth Correlation 12m | 67.4% |
Growth Correlation 5y | 89.7% |
CAGR 5y | 13.79% |
CAGR/Mean DD 5y | 1.39 |
Sharpe Ratio 12m | 1.05 |
Alpha | 10.75 |
Beta | 0.63 |
Volatility | 21.85% |
Current Volume | 339.4k |
Average Volume 20d | 255.3k |
As of January 02, 2025, the stock is trading at USD 78.09 with a total of 339,393 shares traded.
Over the past week, the price has changed by -1.44%, over one month by -8.12%, over three months by +10.25% and over the past year by +25.97%.
Partly, yes. Based on ValueRay Fundamental Analyses, Prestige Brand Holdings (NYSE:PBH) is currently (January 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 57.88 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PBH as of January 2025 is 81.43. This means that PBH is currently overvalued and has a potential downside of 4.28%.
Prestige Brand Holdings has received a consensus analysts rating of 4.13. Therefor, it is recommend to buy PBH.
- Strong Buy: 5
- Buy: 0
- Hold: 2
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, PBH Prestige Brand Holdings will be worth about 88.5 in January 2026. The stock is currently trading at 78.09. This means that the stock has a potential upside of +13.37%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 85.3 | 9.2% |
Analysts Target Price | 72.8 | -6.8% |
ValueRay Target Price | 88.5 | 13.4% |